New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 10, 2014
09:21 EDTRT, HPQ, QLYS, EBAY, CSH, RAD, FEYE, PIR, MRK, BBBY, IMPVOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Rite Aid (RAD), up 13%... Ruby Tuesday (RT), up 7%... Pier 1 Imports (PIR), up 4%. ALSO HIGHER: Merck (MRK), up 1.5% after announcing data from C-WORTHy study... Cash America (CSH), up 15% after earnings report, announcing plans to evaluate separation of online business... HP (HPQ), up 1.7% after initiated with a Buy at Deutsche Bank. DOWN AFTER EARNINGS: Bed Bath & Beyond (BBBY), down 5.3%. ALSO LOWER: EBAY (EBAY), down 1% after settling proxy contest with Carl Icahn, who withdrew his PayPal spin-off proposal... Imperva (IMPV), down 35% after slashing its first quarter profit and sales outlook, shares downgraded at Deutsche Bank and Oppenheimer. Several of its security software peers are lower in pre-market trade as well, including FireEye (FEYE), which is down 3%, and Qualys (QLYS), which is down 1.5%.
News For EBAY;IMPV;FEYE;QLYS;BBBY;RAD;HPQ;MRK;CSH;RT;PIR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
April 21, 2015
10:01 EDTCSHOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:37 EDTHPQHP sells Snapfish to District Photo ahead of seperation
HP announced a definitive agreement to divest Snapfish, its photo storage and merchandising business. District Photo will acquire the Snapfish business, including technology assets and employees. After the transaction closes, HP will maintain a partnership with Snapfish. Snapfish will continue to use HP printing solutions, and HP will provide the HP Connected Photo application developed by Snapfish on HP consumer PCs, including the Sprout computing platform, the company said. HP expects the transaction to close in the second half of FY15. Financial terms of the deal were not disclosed. It added, "The divestiture is consistent with HPís strategy to focus the organization following HPís previously announced separation."
08:30 EDTMRKMerck reaffirms commitment to developing medicines for infectious diseases
Merck reaffirmed its longstanding commitment to discovering and developing novel medicines in the global fight against infectious diseases, including infections caused by resistant bacteria and other pathogens. At this yearís 25th European Congress of Clinical Microbiology and Infectious Diseases, April 25-28 in Copenhagen, Denmark, researchers are scheduled to present more than 30 scientific data presentations on the companyís broad portfolio of marketed and investigational anti-infective medicines. Merck completed its acquisition of Cubist Pharmaceuticals, Inc. on Jan. 21, 2015, and continues to build on both companiesí work in infectious disease. Antimicrobial research remains an important area of focus. In addition to a combined portfolio of antibiotic and antifungal medicines, vaccines, and medicines for HIV and HCV, Merck has multiple programs that span discovery through late-stage development. In total, Merck currently has more than 15 ongoing clinical trials evaluating antibiotic, antifungal and antiviral agents for the prevention and treatment of infectious disease. These trials are projected to enroll approximately 8,000 patients.
08:04 EDTFEYE, HPQHP, FireEye announce partnership
Subscribe for More Information
07:15 EDTFEYE, QLYSUBS to host a software tour
Software Tour at RSA Conference is being held on April 21-24.
07:06 EDTFEYERe/Code to hold a conference
Subscribe for More Information
06:22 EDTCSHCash America downgraded to Underperform from Neutral at Macquarie
Subscribe for More Information
05:56 EDTHPQStocks with implied volatility movement; CNX HPQ
Subscribe for More Information
April 20, 2015
16:21 EDTBBBYBed Bath & Beyond initiated with a Buy at Cantor
Target $83.
12:35 EDTFEYECybersecurity stocks rally after Raytheon announces joint venture
The shares of cybersecurity companies are rising after Raytheon (RTN), a major defense contractor, announced that it was forming a cybersecuity joint venture with a company in the sector, Websense. Raytheon will acquire control of Websense as part of the deal. WHAT'S NEW: Raytheon announced that it had agreed to form a joint venture with Websense, which is owned by Vista Equity Partners. Under the deal, Websense will combine with Raytheon Cyber Products, a business unit of Raytheon's Intelligence, Information and Services segment. Raytheon will pay about $1.57B for an 80.3% stake in the joint venture. Additionally, Raytheon will pay $1.9B, net of cash acquired, to buy Websense. Of the $1.9B, $600M will be in the form of an intercompany loan to the joint venture. The combined company will be treated as a separate business segment of Raytheon, the defense contractor stated. John McCormack, the CEO of Websense, will be the CEO of the unit. The deal is expected to close next quarter. ANALYST REACTION: In a note to investors earlier today, Wells Fargo analyst Sam Pearlstein wrote that the deal will raise Raytheon's non-GAAP, 2015 adjusted earnings per share by about 6c. However, the transaction will lower Raytheon's EPS on a GAAP basis for 2015 by 48c, driven by amortization of intangibles, deferred revenue, and one-time costs, according to Pearlstein. The analyst kept an Outperform rating on Raytheon shares. WHAT'S NOTABLE: Cybersecurity company Check Point (CHKP) reported stronger than expected first quarter results today. Its Q2 guidance was roughly in-line with analysts' consensus estimates at the midpoints of the ranges given for earnings and revenue. Additionally, Check Point announced a partnership with another cybersecurity company, FireEye (FEYE). The companies said they would share threat intelligence to protect customers from modern advanced attacks. PRICE ACTION: In early afternoon trading,Check Point jumped 5.4% to $86.14, FireEye rose 3.8% to $42.39, Palo Alto (PANW) gained 2.4% to $146, Fortinet (FTNT) added 1.7% to $34.28, Proofpoint (PFPT) advanced 1.7% to $58, and Raytheon slid 0.3% to $107.40.
09:31 EDTRADRite Aid names Steve Rempel as SVP, Chief Information Officer
Rite Aid Corporation announced that Steve Rempel, a highly experienced information technology executive, has been named Rite Aidís senior vice president and chief information officer. In this position, Rempel will have responsibility for all aspects of the companyís technology and information operations, including computer systems, network infrastructure, telecommunications and data security as well as the continued development and execution of Rite Aidís immediate and long-term information technology strategy. Rempel will report to Frank Vitrano, Rite Aidís senior executive vice president and chief administrative officer.
08:25 EDTFEYECheck Point announces new partnership with FireEye
Check Point (CHKP) and FireEye (FEYE) announced a partnership to share threat intelligence to protect customers from modern advanced attacks. As part of this cooperation, Check Point's ThreatCloud and Next Generation Threat Prevention solutions and the FireEye NX platform will share the latest threat intelligence in real-time, allowing customers to update firewall security policies dynamically based on the intelligence from both platforms.
08:05 EDTMRKTetraLogic, Merck enter into oncology clinical study collaboration
Subscribe for More Information
07:20 EDTMRKAmerican Association for Cancer Research to hold annual meeting
Subscribe for More Information
April 19, 2015
19:35 EDTMRKMerck to swiftly repay $5B loan, explore acquisitions by late 2017, Reuters says
Subscribe for More Information
16:51 EDTFEYEFireEye labs detected limited APT campaign
Subscribe for More Information
15:21 EDTMRKMerck announces new data from Keytruda study
Subscribe for More Information
14:59 EDTMRKMerck's Keytruda 'superior' to ipilimumab for PFS in patients with melanoma
Subscribe for More Information
14:47 EDTMRKMerck submits supplemental biologics license for Keytruda in lung cancer
Subscribe for More Information
14:31 EDTMRKMerck reports 28% Keytruda response rate in 25 pleural mesothelioma patients
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use